AI assistant
Sending…
EXPONENT INC — Director's Dealing 2016
Feb 12, 2016
31263_dirs_2016-02-12_a8dfb0c0-7a59-4cc3-9698-590aa316c8c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: EXPONENT INC (EXPO)
CIK: 0000851520
Period of Report: 2016-01-01
Reporting Person: Osteraas John (Group Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-02 | Common Stock | P | 44.0 | $42.313 | Acquired | 5819 | Direct |
| 2015-07-03 | Common Stock | P | 53.0 | $42.712 | Acquired | 4263 | Direct |
| 2015-10-02 | Common Stock | P | 43.0 | $43.605 | Acquired | 4306 | Direct |
| 2016-01-01 | Common Stock | P | 47.0 | $47.4525 | Acquired | 4353 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-01-01 | Dividend Equivalent Rights | $ | A | 74.0 | Acquired | 2016-03-09 | Common Stock (74) | Direct |
| 2016-01-01 | Dividend Equivalent Rights | $ | A | 46.0 | Acquired | 2017-03-15 | Common Stock (46) | Direct |
| 2016-01-01 | Dividend Equivalent Rights | $ | A | 14.0 | Acquired | 2018-03-14 | Common Stock (14) | Direct |
| 2016-01-01 | Dividend Equivalent Rights | $ | A | 18.0 | Acquired | 2019-03-13 | Common Stock (18) | Direct |
Footnotes
F1: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3.
F2: 1-for-1.
F3: The dividend equivalent rights accrued with respect to RSUs, pursuant to dividends earned in 2015.
F4: Not applicable.
More from EXPONENT INC
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 20
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 27